Literature DB >> 12089504

The treatment outcome of trigger thumb in children.

Andrew Hwee Chye Tan1, Khee Sien Lam, Eng Hin Lee.   

Abstract

Our objectives were to determine the treatment outcome of trigger thumb and to identify its possible cause. One hundred and thirty-eight thumbs from 115 children were reviewed. There was an overall success rate of 66% following conservative treatment and the success rate appears to be higher in the younger age group and in those treated with splint therapy, which includes wearing a splint and regular therapy exercises. The outcome of the children who underwent surgery was good with a recurrence rate of 1.4% and a wound infection rate of 2.8%. Our results suggest that a more conservative approach to this problem should be adopted. Our data also suggest that this condition may be acquired rather than congenital.

Entities:  

Mesh:

Year:  2002        PMID: 12089504     DOI: 10.1097/00009957-200207000-00011

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  5 in total

1.  Risk stratification for the recurrence of trigger thumb after surgical release in the paediatric patient.

Authors:  D S Edwards; R H Richards
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-06-29

2.  Treatment of common congenital hand conditions.

Authors:  Takashi Oda; Allison G Pushman; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2010-09       Impact factor: 4.730

3.  Complete annular and partial oblique pulley release for pediatric locked trigger thumb.

Authors:  Meiying Kuo; Ghazi M Rayan
Journal:  Hand (N Y)       Date:  2010-05-19

4.  The natural history of pediatric trigger thumb: a study with a minimum of five years follow-up.

Authors:  Goo Hyun Baek; Hyuk Jin Lee
Journal:  Clin Orthop Surg       Date:  2011-05-12

5.  Treatment of paediatric trigger finger: a systematic review and treatment algorithm.

Authors:  M E Womack; J C Ryan; V Shillingford-Cole; S Speicher; G D Hogue
Journal:  J Child Orthop       Date:  2018-06-01       Impact factor: 1.548

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.